Scam, kidnap by South African police

Scam, kidnap by South African police

Medical Writing Institute click here

MJoTAtalks click here

Emerald Pademelon Press LLC click here


Peace Scientists click here

Dr Susanna loves the countries and the peoples of Africa

Scam, kidnap by South African police

Scam, kidnap by South African police

 
Bookmark and Share
Don't get diabetes! Take care of yourself if you have it! Diabetes resources, click here.
Diabetes News
Clinical trials testing therapies for diabetes

Latest Top (15) News


"Outcome of Diabetes Education Among Renal Transplant Recipients With New Onset Diabetes After Transplantation (NODAT)"
Conditions:   New Onset Diabetes After Transplant;   Diabetes Mellitus
Intervention:   Other: group education
Sponsor:   Dasman Diabetes Institute
Completed

Tue, 23 Jul 2019 12:00:00 EDT


Ertugliflozin Type 2 Diabetes Mellitus (T2DM) Pediatric Study (MK-8835/PF-04971729) (MK-8835-059)
Condition:   Type 2 Diabetes Mellitus
Interventions:   Drug: Ertugliflozin 5 mg;   Drug: Ertugliflozin 15 mg;   Drug: Placebo;   Biological: Insulin;   Drug: Metformin
Sponsors:   Merck Sharp & Dohme Corp.;   Pfizer
Not yet recruiting

Tue, 23 Jul 2019 12:00:00 EDT


Evaluation of The Effectiveness of m-DAKBAS on Foot Care
Conditions:   Diabetic Foot;   Foot Ulcer, Diabetic;   Health Knowledge, Attitudes, Practice
Intervention:   Other: knowledge, behaviour, self efficacy
Sponsors:   Sanko University;   Koç University
Completed

Tue, 23 Jul 2019 12:00:00 EDT


Home-based Prediabetes Care in Acoma Pueblo - Study 1
Condition:   PreDiabetes
Intervention:   Behavioral: Lifestyle Interventions
Sponsor:   University of New Mexico
Not yet recruiting

Tue, 23 Jul 2019 12:00:00 EDT


IN Insulin in Type 1 Diabetes (T1D) Hypoglycemia Unawareness: Safety Only Phase
Condition:   Type1diabetes
Interventions:   Drug: Regular insulin (Humulin-R), intranasal route;   Device: SipNose intranasal device
Sponsors:   HealthPartners Institute;   International Diabetes Center at Park Nicollet;   Juvenile Diabetes Research Foundation
Not yet recruiting

Tue, 23 Jul 2019 12:00:00 EDT


Molecular Analysis of Diabetic Kidney Disease Biopsies
Conditions:   Diabetic Nephropathies;   Kidney Disease, Chronic
Intervention:   Other: RNA sequencing
Sponsors:   St. Michael's Hospital, Toronto;   University of Ottawa;   University of British Columbia;   University of Manitoba
Recruiting

Tue, 23 Jul 2019 12:00:00 EDT


Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus
Conditions:   Diabetes Mellitus, Type 2;   Diabetes Mellitus, Type 1
Interventions:   Drug: 3 hours humulin R 100 IU/mL PIT;   Drug: 2 hours humulin R 100 IU/mL PIT
Sponsors:   Sciema UG;   Innovative Diabetes Treatment Studies LLC.
Not yet recruiting

Tue, 23 Jul 2019 12:00:00 EDT


The Causal Effects of Old Age Pensions
Condition:   Aging
Intervention:   Behavioral: Assistance with old age pension application
Sponsor:   National Bureau of Economic Research, Inc.
Active, not recruiting

Tue, 23 Jul 2019 12:00:00 EDT


Families Becoming Healthy Together
Conditions:   Obesity;   Childhood Obesity
Interventions:   Behavioral: FBT;   Behavioral: FBT+Variety
Sponsors:   The University of Tennessee, Knoxville;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);   The Miriam Hospital;   University of Memphis;   University at Buffalo
Recruiting

Mon, 22 Jul 2019 12:00:00 EDT


Impact of ACT-based Interventions on Diabetes-related Outcomes
Conditions:   Diabetes Mellitus, Type 1;   Diabetes Mellitus, Type 2
Interventions:   Behavioral: Values-plus-goals intervention;   Behavioral: Mindfulness-based intervention
Sponsor:   Sophini Logeswaran
Not yet recruiting

Mon, 22 Jul 2019 12:00:00 EDT


Improving Diabetes Medication Adherence for African Americans in Madison and Milwaukee Through Peer Support
Conditions:   Type2 Diabetes;   Medication Adherence;   Medication Nonadherence;   Peer Support
Intervention:   Behavioral: Peers Supporting Health-Literacy, Self Efficacy, Advocacy and Adherence
Sponsor:   University of Wisconsin, Madison
Recruiting

Mon, 22 Jul 2019 12:00:00 EDT


Platelet Activity in T2DM Using Flowcytometry
Condition:   Platelet Activity in T2DM Using Flowcytometry
Intervention:   Other: Flowcytometry
Sponsor:   Assiut University
Not yet recruiting

Mon, 22 Jul 2019 12:00:00 EDT


Platelet Reactivity, B-amyloid, MOTS-c and Mortality of Type II Diabetics With CAD
Conditions:   Diabetes;   Clopidogrel Resistance;   Amyloid;   Insulin Resistance
Intervention:  
Sponsor:   University of Athens
Active, not recruiting

Mon, 22 Jul 2019 12:00:00 EDT


Prevention of Gestational Diabetes
Condition:   Gestational Diabetes
Interventions:   Behavioral: Diet Modification Group;   Other: Regular Diet Group
Sponsor:   University Hospital Tuebingen
Recruiting

Mon, 22 Jul 2019 12:00:00 EDT


Renal Oxygenation, Oxygen Consumption and Hemodynamic Kinetics in Type 2 DIabetes: an Ertugliflozin Study.
Conditions:   Type 2 Diabetes Mellitus;   Diabetic Kidney Disease;   Diabetic Nephropathy;   Renal Hypoxia;   Renoprotection;   SGLT2 Inhibitor;   Ertugliflozin
Intervention:   Drug: Ertugliflozin 15 mg
Sponsor:   VU University Medical Center
Not yet recruiting

Mon, 22 Jul 2019 12:00:00 EDT
FDA (Food and Drug Administration) press releases. FDA makes sure of the safety of all medicines which can be injected, breathed in, rubbed in and swallowed, in the United States of America.

Latest Top (10) News


FDA approves first generics of Lyrica
FDA approves first generics of Lyrica (pregabalin)




FDA approves first treatment for chronic rhinosinusitis with nasal polyps
FDA approves Dupixent to treat adults with nasal polyps accompanied by chronic rhinosinusitis or prolonged inflammation of the sinuses and nasal cavity.




FDA approves first treatment for neuromyelitis optica spectrum disorder, a rare autoimmune disease of the central nervous system
FDA approves Soliris (eculizumab) injection for intravenous use for the treatment of neuromyelitis optica spectrum disorder (NMOSD) in adult patients who are anti-aquaporin-4 (AQP4) antibody positive.




FDA approves new treatment for complicated urinary tract and complicated intra-abdominal infections
FDA approved Recarbrio, an antibacterial drug to treat adults with complicated urinary tract infections (cUTI) and complicated intra-abdominal infections (cIAI).




FDA approves new treatment for hypoactive sexual desire disorder in premenopausal women
FDA approved Vyleesi (bremelanotide) to treat acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women.




FDA approves new treatment for refractory multiple myeloma
FDA grants accelerated approval to Xpovio (selinexor) tablets in combination with the corticosteroid dexamethasone for the treatment of adult patients with relapsed refractory multiple myeloma (RRMM) who have received at least four prior therapies and whose disease is resistant to several other form




FDA expands approval of treatment for cystic fibrosis to include patients ages 6 and older
FDA expanded the indication for Symdeko for treatment of pediatric patients ages 6 years and older with cystic fibrosis who have certain genetic mutations.




FDA issues third status report on investigation into potential connection between certain diets and cases of canine heart disease
This press release highlights an update on the FDA’s investigation into a potential connection between certain diets and cases of canine heart disease




FDA issues warnings to companies selling illegal, unapproved kratom drug products marketed for opioid cessation, pain treatment and other medical uses
FDA issued warning letters to two marketers and distributors of kratom products – Cali Botanicals and Kratom NC– for illegally selling unapproved, misbranded kratom-containing drug products with unproven claims about their ability to treat or cure opioid addiction and withdrawal symptoms.




FDA launches its first youth e-cigarette prevention TV ads, plans new educational resources as agency approaches one-year anniversary of public education campaign
FDA is launching its first youth e-cigarette prevention TV ads and is planning to provide new educational resources as agency approaches one-year anniversary of public education campaign.


Diabetes news from the American Diabetes Association

Latest Top (5) News